14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $18.05 $25.44 Wednesday, 1st May 2024 PHVS stock ended at $24.57. This is 0.0813% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.64% from a day low at $23.16 to a day high of $25.16.
90 days $18.05 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
Oct 31, 2023 $17.64 $18.19 $17.00 $17.01 14 202
Oct 30, 2023 $17.98 $18.49 $16.41 $16.96 6 642
Oct 27, 2023 $17.99 $17.99 $17.41 $17.72 3 526
Oct 26, 2023 $18.25 $19.00 $17.20 $18.30 17 211
Oct 25, 2023 $18.32 $18.75 $17.30 $18.75 21 254
Oct 24, 2023 $17.74 $20.27 $17.24 $18.79 19 886
Oct 23, 2023 $17.00 $18.34 $17.00 $17.89 36 091
Oct 20, 2023 $18.70 $18.70 $16.91 $17.29 26 205
Oct 19, 2023 $19.95 $19.95 $18.51 $18.79 8 920
Oct 18, 2023 $20.00 $20.00 $18.97 $19.80 7 135
Oct 17, 2023 $19.25 $20.98 $17.00 $20.50 198 376
Oct 16, 2023 $18.85 $19.50 $18.37 $19.40 5 674
Oct 13, 2023 $19.19 $19.84 $18.75 $18.90 10 050
Oct 12, 2023 $19.28 $19.84 $17.90 $19.00 41 341
Oct 11, 2023 $19.98 $19.98 $19.21 $19.85 3 859
Oct 10, 2023 $18.45 $20.08 $18.45 $20.06 5 688
Oct 09, 2023 $19.00 $20.19 $18.61 $19.22 18 289
Oct 06, 2023 $19.03 $20.43 $19.03 $20.07 11 546
Oct 05, 2023 $18.51 $19.62 $18.51 $19.19 16 352
Oct 04, 2023 $18.59 $19.43 $18.22 $19.40 12 824
Oct 03, 2023 $18.03 $18.72 $18.00 $18.55 15 033
Oct 02, 2023 $20.55 $20.55 $18.33 $18.50 63 214
Sep 29, 2023 $20.00 $20.97 $19.86 $20.87 32 608
Sep 28, 2023 $21.16 $21.91 $18.97 $20.27 46 290
Sep 27, 2023 $20.53 $21.26 $20.12 $21.26 36 206
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT